Company registration number 13898682 (England and Wales)
SHIRES GROUP HOLDINGS LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2025
PAGES FOR FILING WITH REGISTRAR
SHIRES GROUP HOLDINGS LIMITED
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 3
SHIRES GROUP HOLDINGS LIMITED
BALANCE SHEET
AS AT
30 NOVEMBER 2025
30 November 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Investments
2
100
100
Current assets
Debtors
4
100
100
Net current assets
100
100
Net assets
200
200
Capital and reserves
Called up share capital
200
200

For the financial year ended 30 November 2025 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved and signed by the director and authorised for issue on 21 August 2026
Mr P Cattee
Director
Company registration number 13898682 (England and Wales)
SHIRES GROUP HOLDINGS LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2025
- 2 -
1
Accounting policies
Company information

Shires Group Holdings Limited is a private company limited by shares incorporated in England and Wales. The registered office is 11 Manchester Road, Walkden, Manchester, M28 3NS.

1.1
Basis of preparation

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention.

The company has taken advantage of the exemption under section 399 of the Companies Act 2006 not to prepare consolidated accounts, on the basis that the group of which this is the parent qualifies as a small group. The financial statements present information about the company as an individual entity and not about its group.

1.2
Profit and loss account

The company has not traded during the year or the preceding financial period. During this time, the company received no income and incurred no expenditure and therefore no Profit and loss account is presented in these financial statements.

1.3
Fixed asset investments

Investments in subsidiaries are measured at cost less impairment.

2
Fixed asset investments
2025
2024
Notes
£
£
Investments in subsidiaries
3
100
100
3
Subsidiaries

Details of the company's subsidiaries at 30 November 2025 are as follows:

Name of undertaking
Registered office
Class of
% Held
shares held
Direct
Shires Pharmacies Limited
31 Manchester Road, Walkden, Manchester M28 3NS
Ordinary
100.00
4
Debtors
2025
2024
Amounts falling due within one year:
£
£
Other debtors
100
100
SHIRES GROUP HOLDINGS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 NOVEMBER 2025
- 3 -
5
Ultimate controlling party

The company's immediate parent is PCT Healthcare Limited, incorporated in England.

 

The ultimate parent is PCT Healthcare (Holdings) Ltd, incorporated in England.

2025-11-302024-12-01falsefalsetrue21 August 2026CCH SoftwareCCH Accounts Production 2026.100No description of principal activityMr P Cattee138986822024-12-012025-11-30138986822025-11-30138986822024-11-3013898682core:ShareCapital2025-11-3013898682core:ShareCapital2024-11-3013898682bus:Director12024-12-012025-11-3013898682core:Non-currentFinancialInstruments2025-11-3013898682core:Non-currentFinancialInstruments2024-11-3013898682core:Subsidiary12024-12-012025-11-3013898682core:Subsidiary112024-12-012025-11-3013898682core:CurrentFinancialInstruments2025-11-3013898682core:CurrentFinancialInstruments2024-11-3013898682bus:EntityNoLongerTradingButTradedInPast2024-12-012025-11-3013898682bus:PrivateLimitedCompanyLtd2024-12-012025-11-3013898682bus:SmallCompaniesRegimeForAccounts2024-12-012025-11-3013898682bus:FRS1022024-12-012025-11-3013898682bus:AuditExemptWithAccountantsReport2024-12-012025-11-3013898682bus:FullAccounts2024-12-012025-11-30xbrli:purexbrli:sharesiso4217:GBP